Dataset Information

High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types

ABSTRACT:

Background

A regional skin cancer prevention program in Eastern Finland revealed a relatively high age-standardized mortality due to malignant melanoma during 2013–2017. An explanation for this is needed.

Purpose

To analyse the 543 melanoma samples in 524 subjects collected during 2000–2013 at Kuopio University Hospital and reposited in the Biobank of Eastern Finland. A focus was directed to factors related to metastasis.

Methods

The samples were analysed anonymously by examining the histopathological report, referral text and the list of diagnoses. A possible state of immunosuppression was evaluated.

Results

The mean age at the diagnosis of malignant melanoma (MM), lentigo maligna (LM) and melanoma in situ was relatively high, i.e., 66.2, 72.1 and 63.3, respectively. Especially the MM type increased markedly during 2000–2013. In further analyses of a representative cohort of 337 samples, the proportion of nodular melanoma and LM/LMM melanoma was relatively high, 35.6 and 22.0%, respectively, but that from superficial spreading melanoma relatively low (33.8%). Metastasis correlated with immunosuppression, male gender, Clark level, Breslow thickness, ulceration, mitosis count, invasion into vessels and/or perineural area, microsatellites, melanoma subtype, body site, recidivism, and the absence of dysplastic nevus cells.

Conclusion

The marked increase in aggressive melanomas with associated metastasis, and the relatively high age at diagnosis, can partially explain the mortality.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12885-021-08879-1.

SUBMITTER: Suhonen V

PROVIDER: S-EPMC8555296 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundMalignant melanoma is an exceptionally aggressive, drug-resistant and heterogeneous cancer. Recently it has been shown that melanoma cells with high clonogenic and tumourigenic abilities are common, but markers distinguishing such cells from cells lacking these abilities have not been identified. There is therefore no definite evidence that an exclusive cell subpopulation, i.e. cancer stem cells (CSC), exists in malignant melanoma. Rather, it is suggested that multiple cell populations are implicated in initiation and progression of the disease, making it of importance to identify subpopulations with elevated aggressive properties.Methods and findingsIn several other cancer forms, Aldehyde Dehydrogenase (ALDH), which plays a role in stem cell biology and resistance, is a valuable functional marker for identification of cells that show enhanced aggressiveness and drug-resistance. Furthermore, the presence of ALDH(+) cells is linked to poor clinical prognosis in these cancers. By analyzing cell cultures, xenografts and patient biopsies, we showed that aggressive melanoma harboured a large, distinguishable ALDH(+) subpopulation. In vivo, ALDH(+) cells gave rise to ALDH(-) cells, while the opposite conversion was rare, indicating a higher abilities of ALDH(+) cells to reestablish tumour heterogeneity with respect to the ALDH phenotype. However, both ALDH(+) and ALDH(-) cells demonstrated similarly high abilities for clone formation in vitro and tumour initiation in vivo. Furthermore, both subpopulations showed similar sensitivity to the anti-melanoma drugs, dacarbazine and lexatumumab.ConclusionsThese findings suggest that ALDH does not distinguish tumour-initiating and/or therapy-resistant cells, implying that the ALDH phenotype is not associated with more-aggressive subpopulations in malignant melanoma, and arguing against ALDH as a "universal" marker. Besides, it was shown that the ability to reestablish tumour heterogeneity is not necessarily linked to the more aggressive phenotype.

Project description:The aim of this study was to assess regional differences in temperature-mortality relationships across 21 hospital districts in Finland. The temperature dependence of the daily number of all-cause, all-aged deaths during 2000-2014 was studied in each hospital district by using daily mean temperatures, spatially averaged across each hospital district, to describe exposure to heat stress and cold stress. The relationships were modelled using distributed lag non-linear models (DLNM). In a simple model version, no delayed impacts of heat and cold on mortality were taken into account, whereas a more complex version included delayed impacts up to 25 days. A meta-analysis with selected climatic and sociodemographic covariates was conducted to study differences in the relationships between hospital districts. A pooled mortality-temperature relationship was produced to describe the average relationship in Finland. The simple DLNM model version without lag gave U-shaped dependencies of mortality on temperature almost without exception. The outputs of the model version with a 25-day lag were also U-shaped in most hospital districts. According to the meta-analysis, the differences in the temperature-mortality relationships between hospital districts were not statistically significant on the absolute temperature scale, meaning that the pooled mortality-temperature relationship can be applied to the whole country. However, on a relative temperature scale, heterogeneity was found, and the meta-regression suggested that morbidity index and population in the hospital districts might explain some of this heterogeneity. The pooled estimate for the relative risk (RR) of mortality at a daily mean temperature of 24 °C was 1.16 (95% CI 1.12-1.20) with reference at 14 °C, which is the minimum mortality temperature (MMT) of the pooled relationship. On the cold side, the RR at a daily mean temperature of -20 °C was 1.14 (95% CI 1.12-1.16). On a relative scale of daily mean temperature, the MMT was found at the 79th percentile.